Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

PYXS

Pyxis Oncology (PYXS)

Pyxis Oncology Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PYXS
일자시간출처헤드라인심볼기업
2024/05/1421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
2024/05/1420:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
2024/05/1420:30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
2024/05/0920:30GlobeNewswire Inc.Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
2024/03/2905:30GlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
2024/03/2720:30GlobeNewswire Inc.Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty RightsNASDAQ:PYXSPyxis Oncology Inc
2024/03/2120:30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023NASDAQ:PYXSPyxis Oncology Inc
2024/03/1321:00GlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFANASDAQ:PYXSPyxis Oncology Inc
2024/03/0906:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYXSPyxis Oncology Inc
2024/03/0806:30GlobeNewswire Inc.Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024NASDAQ:PYXSPyxis Oncology Inc
2024/03/0606:45GlobeNewswire Inc.Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual MeetingNASDAQ:PYXSPyxis Oncology Inc
2024/02/2821:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
2024/02/2722:00GlobeNewswire Inc.Pyxis Oncology Announces $50 Million Private PlacementNASDAQ:PYXSPyxis Oncology Inc
2023/12/3006:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
2023/12/3006:30GlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
2023/12/0706:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
2023/12/0106:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
2023/11/2821:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
2023/11/2821:00GlobeNewswire Inc.Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical OfficerNASDAQ:PYXSPyxis Oncology Inc
2023/11/1806:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
2023/11/0806:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
2023/11/0806:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
2023/11/0806:30GlobeNewswire Inc.Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate UpdateNASDAQ:PYXSPyxis Oncology Inc
2023/10/2805:34Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PYXSPyxis Oncology Inc
2023/09/2905:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
2023/09/2807:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
2023/09/2807:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
2023/09/2722:18GlobeNewswire Inc.Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023NASDAQ:PYXSPyxis Oncology Inc
2023/09/2606:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
2023/09/2606:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
 검색 관련기사 보기:NASDAQ:PYXS